Global Spinal Muscular Atrophy (SMA) Treatment Market Insights, Forecast to 2025
- QYR2723708
- 110 Pages
- September 2018
- Medical Devices
This research report categorizes the global Spinal Muscular Atrophy (SMA) Treatment market by top players/brands, region, type and end user. This report also studies the global Spinal Muscular Atrophy (SMA) Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
Spinal muscular atrophy (SMA) refers to a group of inherited diseases that affects the functioning of muscles because of deterioration.
North America dominates the global market for SMA treatment due to the high prevalence of SMA and increased adoption of SMA treatment options in the region.
The global Spinal Muscular Atrophy (SMA) Treatment market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025. The objectives of this study are to define, segment, and project the size of the Spinal Muscular Atrophy (SMA) Treatment market based on company, product type, end user and key regions.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Pfizer
Isis Pharmaceuticals
Biogen Idec
Boehringer Ingelheim
F. Hoffmann-La Roche
Regeneron Pharmaceuticals
Market size by Product
Type I Spinal Muscular Atrophy (SMA)
Type II Spinal Muscular Atrophy (SMA)
Type III Spinal Muscular Atrophy (SMA)
Market size by End User
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Spinal Muscular Atrophy (SMA) Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025.
To understand the structure of Spinal Muscular Atrophy (SMA) Treatment market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Spinal Muscular Atrophy (SMA) Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Spinal Muscular Atrophy (SMA) Treatment submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Spinal Muscular Atrophy (SMA) Treatment are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Spinal Muscular Atrophy (SMA) Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Study Coverage
1.1 Spinal Muscular Atrophy (SMA) Treatment Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate by Product
1.4.2 Type I Spinal Muscular Atrophy (SMA)
1.4.3 Type II Spinal Muscular Atrophy (SMA)
1.4.4 Type III Spinal Muscular Atrophy (SMA)
1.5 Market by End User
1.5.1 Global Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Diagnostic Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Spinal Muscular Atrophy (SMA) Treatment Market Size
2.1.1 Global Spinal Muscular Atrophy (SMA) Treatment Revenue 2013-2025
2.1.2 Global Spinal Muscular Atrophy (SMA) Treatment Sales 2013-2025
2.2 Spinal Muscular Atrophy (SMA) Treatment Growth Rate by Regions
2.2.1 Global Spinal Muscular Atrophy (SMA) Treatment Sales by Regions
2.2.2 Global Spinal Muscular Atrophy (SMA) Treatment Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Spinal Muscular Atrophy (SMA) Treatment Sales by Manufacturers
3.1.1 Spinal Muscular Atrophy (SMA) Treatment Sales by Manufacturers
3.1.2 Spinal Muscular Atrophy (SMA) Treatment Sales Market Share by Manufacturers
3.1.3 Global Spinal Muscular Atrophy (SMA) Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Spinal Muscular Atrophy (SMA) Treatment Revenue by Manufacturers
3.2.1 Spinal Muscular Atrophy (SMA) Treatment Revenue by Manufacturers (2013-2018)
3.2.2 Spinal Muscular Atrophy (SMA) Treatment Revenue Share by Manufacturers (2013-2018)
3.3 Spinal Muscular Atrophy (SMA) Treatment Price by Manufacturers
3.4 Spinal Muscular Atrophy (SMA) Treatment Manufacturing Base Distribution, Product Types
3.4.1 Spinal Muscular Atrophy (SMA) Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Spinal Muscular Atrophy (SMA) Treatment Product Type
3.4.3 Date of International Manufacturers Enter into Spinal Muscular Atrophy (SMA) Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Spinal Muscular Atrophy (SMA) Treatment Sales by Product
4.2 Global Spinal Muscular Atrophy (SMA) Treatment Revenue by Product
4.3 Spinal Muscular Atrophy (SMA) Treatment Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Spinal Muscular Atrophy (SMA) Treatment Breakdown Data by End User
6 North America
6.1 North America Spinal Muscular Atrophy (SMA) Treatment by Countries
6.1.1 North America Spinal Muscular Atrophy (SMA) Treatment Sales by Countries
6.1.2 North America Spinal Muscular Atrophy (SMA) Treatment Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Spinal Muscular Atrophy (SMA) Treatment by Product
6.3 North America Spinal Muscular Atrophy (SMA) Treatment by End User
7 Europe
7.1 Europe Spinal Muscular Atrophy (SMA) Treatment by Countries
7.1.1 Europe Spinal Muscular Atrophy (SMA) Treatment Sales by Countries
7.1.2 Europe Spinal Muscular Atrophy (SMA) Treatment Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Spinal Muscular Atrophy (SMA) Treatment by Product
7.3 Europe Spinal Muscular Atrophy (SMA) Treatment by End User
8 Asia Pacific
8.1 Asia Pacific Spinal Muscular Atrophy (SMA) Treatment by Countries
8.1.1 Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Sales by Countries
8.1.2 Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Spinal Muscular Atrophy (SMA) Treatment by Product
8.3 Asia Pacific Spinal Muscular Atrophy (SMA) Treatment by End User
9 Central & South America
9.1 Central & South America Spinal Muscular Atrophy (SMA) Treatment by Countries
9.1.1 Central & South America Spinal Muscular Atrophy (SMA) Treatment Sales by Countries
9.1.2 Central & South America Spinal Muscular Atrophy (SMA) Treatment Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Spinal Muscular Atrophy (SMA) Treatment by Product
9.3 Central & South America Spinal Muscular Atrophy (SMA) Treatment by End User
10 Middle East and Africa
10.1 Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment by Countries
10.1.1 Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Sales by Countries
10.1.2 Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment by Product
10.3 Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment by End User
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Business Overview
11.1.3 Pfizer Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue and Gross Margin (2013-2018)
11.1.4 Pfizer Spinal Muscular Atrophy (SMA) Treatment Products Offered
11.1.5 Pfizer Recent Development
11.2 Isis Pharmaceuticals
11.2.1 Isis Pharmaceuticals Company Details
11.2.2 Company Business Overview
11.2.3 Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue and Gross Margin (2013-2018)
11.2.4 Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Products Offered
11.2.5 Isis Pharmaceuticals Recent Development
11.3 Biogen Idec
11.3.1 Biogen Idec Company Details
11.3.2 Company Business Overview
11.3.Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue and Gross Margin (2013-2018)
11.3.4 Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Products Offered
11.3.5 Biogen Idec Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Details
11.4.2 Company Business Overview
11.4.3 Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue and Gross Margin (2013-2018)
11.4.4 Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Products Offered
11.4.5 Boehringer Ingelheim Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Details
11.5.2 Company Business Overview
11.5.3 F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue and Gross Margin (2013-2018)
11.5.4 F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Products Offered
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 Regeneron Pharmaceuticals
11.6.1 Regeneron Pharmaceuticals Company Details
11.6.2 Company Business Overview
11.6.3 Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue and Gross Margin (2013-2018)
11.6.4 Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Products Offered
11.6.5 Regeneron Pharmaceuticals Recent Development
12 Future Forecast
12.1 Spinal Muscular Atrophy (SMA) Treatment Market Forecast by Regions
12.1.1 Global Spinal Muscular Atrophy (SMA) Treatment Sales Forecast by Regions 2018-2025
12.1.2 Global Spinal Muscular Atrophy (SMA) Treatment Revenue Forecast by Regions 2018-2025
12.2 Spinal Muscular Atrophy (SMA) Treatment Market Forecast by Product
12.2.1 Global Spinal Muscular Atrophy (SMA) Treatment Sales Forecast by Product 2018-2025
12.2.2 Global Spinal Muscular Atrophy (SMA) Treatment Revenue Forecast by Product 2018-2025
12.3 Spinal Muscular Atrophy (SMA) Treatment Market Forecast by End User
12.4 North America Spinal Muscular Atrophy (SMA) Treatment Forecast
12.5 Europe Spinal Muscular Atrophy (SMA) Treatment Forecast
12.6 Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Forecast
12.7 Central & South America Spinal Muscular Atrophy (SMA) Treatment Forecast
12.8 Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Spinal Muscular Atrophy (SMA) Treatment Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Spinal Muscular Atrophy (SMA) Treatment Product Picture
Table Spinal Muscular Atrophy (SMA) Treatment Market Segments
Table Key Manufacturers Spinal Muscular Atrophy (SMA) Treatment Covered
Table Global Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate by Product 2018-2025 (K Units) & (Million US$)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Sales Market Share by Product 2013-2025
Figure Type I Spinal Muscular Atrophy (SMA) Product Picture
Table Major Manufacturers of Type I Spinal Muscular Atrophy (SMA)
Figure Type II Spinal Muscular Atrophy (SMA) Product Picture
Table Major Manufacturers of Type II Spinal Muscular Atrophy (SMA)
Figure Type III Spinal Muscular Atrophy (SMA) Product Picture
Table Major Manufacturers of Type III Spinal Muscular Atrophy (SMA)
Table Global Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate by End User 2018-2025 (K Units)
Figure Hospitals
Figure Ambulatory Surgical Centers
Figure Diagnostic Centers
Figure Others
Figure Spinal Muscular Atrophy (SMA) Treatment Report Years Considered
Figure Global Spinal Muscular Atrophy (SMA) Treatment Market Size 2013-2025 (Million US$)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Sales 2013-2025 (K Units)
Table Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Regions 2013-2018 (K Units) & (Million US$)
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales by Regions 2013-2018 (K Units)
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales Market Share by Regions 2013-2018
Figure Global Spinal Muscular Atrophy (SMA) Treatment Sales Market Share by Regions 2013-2018
Figure 2017 Global Spinal Muscular Atrophy (SMA) Treatment Sales Market Share by Regions
Table Global Spinal Muscular Atrophy (SMA) Treatment Revenue by Regions 2013-2018 (Million US$)
Table Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Regions 2013-2018
Figure Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Regions 2013-2018
Figure 2017 Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Regions
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales by Manufacturers (2013-2018) (K Units)
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales Share by Manufacturers (2013-2018)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Sales Share by Manufacturers in 2017
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Spinal Muscular Atrophy (SMA) Treatment Revenue by Manufacturers (2013-2018) (Million USD)
Table Spinal Muscular Atrophy (SMA) Treatment Revenue Share by Manufacturers (2013-2018)
Figure Spinal Muscular Atrophy (SMA) Treatment Value Share by Manufacturers in 2017
Table Key Manufacturers Spinal Muscular Atrophy (SMA) Treatment Price (2013-2018) (USD/Unit)
Table Spinal Muscular Atrophy (SMA) Treatment Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Spinal Muscular Atrophy (SMA) Treatment Product Type
Table Date of International Manufacturers Enter into Spinal Muscular Atrophy (SMA) Treatment Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales by Product (2013-2018) (K Units)
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales Share by Product (2013-2018)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Sales Market Share by Product (2013-2018)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Sales Market Share by Product in 2017
Table Global Spinal Muscular Atrophy (SMA) Treatment Revenue by Product (2013-2018) (Million US$)
Table Global Spinal Muscular Atrophy (SMA) Treatment Revenue Share by Product (2013-2018)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Product (2013-2018)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Product in 2017
Table Spinal Muscular Atrophy (SMA) Treatment Price by Product 2013-2018 (USD/Unit)
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales by End User (2013-2018) (K Units)
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales Share by End User (2013-2018)
Figure Global Sales Spinal Muscular Atrophy (SMA) Treatment Market Share by End User (2013-2018)
Figure Global Sales Spinal Muscular Atrophy (SMA) Treatment Market Share by End User in 2017
Figure North America Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate 2013-2018 (K Units)
Figure North America Spinal Muscular Atrophy (SMA) Treatment Revenue Growth Rate 2013-2018 (Million US$)
Table North America Spinal Muscular Atrophy (SMA) Treatment Sales by Countries (2013-2018) (K Units)
Table North America Spinal Muscular Atrophy (SMA) Treatment Sales Market Share by Countries (2013-2018)
Figure 2017 North America Spinal Muscular Atrophy (SMA) Treatment Sales Market Share by Countries
Table North America Spinal Muscular Atrophy (SMA) Treatment Revenue by Countries (2013-2018) (Million US$)
Table North America Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Countries (2013-2018)
Figure 2017 North America Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Countries
Figure United States Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate (2013-2018) (K Units)
Figure United States Spinal Muscular Atrophy (SMA) Treatment Revenue Growth Rate (2013-2018) (K Units)
Figure Canada Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate (2013-2018) (K Units)
Figure Canada Spinal Muscular Atrophy (SMA) Treatment Revenue Growth Rate (2013-2018) (Million US$)
Figure Mexico Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate (2013-2018) (K Units)
Figure Mexico Spinal Muscular Atrophy (SMA) Treatment Revenue Growth Rate (2013-2018) (Million US$)
Table North America Spinal Muscular Atrophy (SMA) Treatment Sales by Product (2013-2018) (K Units)
Table North America Spinal Muscular Atrophy (SMA) Treatment Sales Market Share by Product (2013-2018)
Figure 2017 North America Spinal Muscular Atrophy (SMA) Treatment Market Share by Product
Table North America Spinal Muscular Atrophy (SMA) Treatment Sales by End User (2013-2018) (K Units)
Table North America Spinal Muscular Atrophy (SMA) Treatment Sales Market Share by End User (2013-2018)
Figure 2017 North America Spinal Muscular Atrophy (SMA) Treatment Market Share by End User
Figure Europe Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate 2013-2018 (K Units)
Figure Europe Spinal Muscular Atrophy (SMA) Treatment Revenue Growth Rate 2013-2018 (Million US$)
Table Europe Spinal Muscular Atrophy (SMA) Treatment Sales by Countries (2013-2018) (K Units)
Table Europe Spinal Muscular Atrophy (SMA) Treatment Sales Market Share by Countries (2013-2018)
Figure 2017 Europe Spinal Muscular Atrophy (SMA) Treatment Sales Market Share by Countries
Table Europe Spinal Muscular Atrophy (SMA) Treatment Revenue by Countries (2013-2018) (Million US$)
Table Europe Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Countries (2013-2018)
Figure 2017 Europe Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Countries
Figure Germany Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate (2013-2018) (K Units)
Figure Germany Spinal Muscular Atrophy (SMA) Treatment Revenue Growth Rate (2013-2018) (Million US$)
Figure France Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate (2013-2018) (K Units)
Figure France Spinal Muscular Atrophy (SMA) Treatment Revenue Growth Rate (2013-2018) (Million US$)
Figure UK Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate (2013-2018) (K Units)
Figure UK Spinal Muscular Atrophy (SMA) Treatment Revenue Growth Rate (2013-2018) (Million US$)
Figure Italy Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate (2013-2018) (K Units)
Figure Italy Spinal Muscular Atrophy (SMA) Treatment Revenue Growth Rate (2013-2018) (Million US$)
Figure Russia Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate (2013-2018) (K Units)
Figure Russia Spinal Muscular Atrophy (SMA) Treatment Revenue Growth Rate (2013-2018) (Million US$)
Table Europe Spinal Muscular Atrophy (SMA) Treatment Sales by Product (2013-2018) (K Units)
Table Europe Spinal Muscular Atrophy (SMA) Treatment Sales Market Share by Product (2013-2018)
Figure 2017 Europe Spinal Muscular Atrophy (SMA) Treatment Market Share by Product
Table Europe Spinal Muscular Atrophy (SMA) Treatment Sales by End User (2013-2018) (K Units)
Table Europe Spinal Muscular Atrophy (SMA) Treatment Sales Market Share by End User (2013-2018)
Figure 2017 Europe Spinal Muscular Atrophy (SMA) Treatment Market Share by End User
Figure Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate 2013-2018 (K Units)
Figure Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Revenue Growth Rate 2013-2018 (Million US$)
Table Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Sales by Countries (2013-2018) (K Units)
Table Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Sales Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Sales Market Share by Countries
Table Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Revenue by Countries (2013-2018) (Million US$)
Table Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Countries
Figure China Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate (2013-2018) (K Units)
Figure China Spinal Muscular Atrophy (SMA) Treatment Revenue Growth Rate (2013-2018) (Million US$)
Figure Japan Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate (2013-2018) (K Units)
Figure Japan Spinal Muscular Atrophy (SMA) Treatment Revenue Growth Rate (2013-2018) (Million US$)
Figure Korea Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate (2013-2018) (K Units)
Figure Korea Spinal Muscular Atrophy (SMA) Treatment Revenue Growth Rate (2013-2018) (Million US$)
Figure India Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate (2013-2018) (K Units)
Figure India Spinal Muscular Atrophy (SMA) Treatment Revenue Growth Rate (2013-2018) (Million US$)
Figure Australia Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate (2013-2018) (K Units)
Figure Australia Spinal Muscular Atrophy (SMA) Treatment Revenue Growth Rate (2013-2018) (Million US$)
Figure Indonesia Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate (2013-2018) (K Units)
Figure Indonesia Spinal Muscular Atrophy (SMA) Treatment Revenue Growth Rate (2013-2018) (Million US$)
Figure Malaysia Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate (2013-2018) (K Units)
Figure Malaysia Spinal Muscular Atrophy (SMA) Treatment Revenue Growth Rate (2013-2018) (Million US$)
Figure Philippines Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate (2013-2018) (K Units)
Figure Philippines Spinal Muscular Atrophy (SMA) Treatment Revenue Growth Rate (2013-2018) (Million US$)
Figure Thailand Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate (2013-2018) (K Units)
Figure Thailand Spinal Muscular Atrophy (SMA) Treatment Revenue Growth Rate (2013-2018) (Million US$)
Figure Vietnam Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate (2013-2018) (K Units)
Figure Vietnam Spinal Muscular Atrophy (SMA) Treatment Revenue Growth Rate (2013-2018) (Million US$)
Figure Singapore Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate (2013-2018) (K Units)
Figure Singapore Spinal Muscular Atrophy (SMA) Treatment Revenue Growth Rate (2013-2018) (Million US$)
Table Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Sales by Product (2013-2018) (K Units)
Table Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Sales Market Share by Product (2013-2018)
Figure 2017 Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Share by Product
Table Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Sales by End User (2013-2018) (K Units)
Table Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Sales Market Share by End User (2013-2018)
Figure 2017 Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Share by End User
Figure Central & South America Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate 2013-2018 (K Units)
Figure Central & South America Spinal Muscular Atrophy (SMA) Treatment Revenue Growth Rate 2013-2018 (Million US$)
Table Central & South America Spinal Muscular Atrophy (SMA) Treatment Sales by Countries (2013-2018) (K Units)
Table Central & South America Spinal Muscular Atrophy (SMA) Treatment Sales Market Share by Countries (2013-2018)
Figure 2017 Central & South America Spinal Muscular Atrophy (SMA) Treatment Sales Market Share by Countries
Table Central & South America Spinal Muscular Atrophy (SMA) Treatment Revenue by Countries (2013-2018) (Million US$)
Table Central & South America Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Countries (2013-2018)
Figure 2017 Central & South America Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Countries
Figure Brazil Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate (2013-2018) (K Units)
Figure Brazil Spinal Muscular Atrophy (SMA) Treatment Revenue Growth Rate (2013-2018) (Million US$)
Figure Argentina Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate (2013-2018) (K Units)
Figure Argentina Spinal Muscular Atrophy (SMA) Treatment Revenue Growth Rate (2013-2018) (Million US$)
Table Central & South America Spinal Muscular Atrophy (SMA) Treatment Sales by Product (2013-2018) (K Units)
Table Central & South America Spinal Muscular Atrophy (SMA) Treatment Sales Market Share by Product (2013-2018)
Figure 2017 Central & South America Spinal Muscular Atrophy (SMA) Treatment Market Share by Product
Table Central & South America Spinal Muscular Atrophy (SMA) Treatment Sales by End User (2013-2018) (K Units)
Table Central & South America Spinal Muscular Atrophy (SMA) Treatment Sales Market Share by End User (2013-2018)
Figure 2017 Central & South America Spinal Muscular Atrophy (SMA) Treatment Market Share by End User
Figure Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate 2013-2018 (K Units)
Figure Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Revenue Growth Rate 2013-2018 (Million US$)
Table Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Sales by Countries (2013-2018) (K Units)
Table Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Sales Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Sales Market Share by Countries
Table Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Revenue by Countries (2013-2018) (Million US$)
Table Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Countries
Figure GCC Countries Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate (2013-2018) (K Units)
Figure GCC Countries Spinal Muscular Atrophy (SMA) Treatment Revenue Growth Rate (2013-2018) (Million US$)
Figure Turkey Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate (2013-2018) (K Units)
Figure Turkey Spinal Muscular Atrophy (SMA) Treatment Revenue Growth Rate (2013-2018) (Million US$)
Figure Egypt Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate (2013-2018) (K Units)
Figure Egypt Spinal Muscular Atrophy (SMA) Treatment Revenue Growth Rate (2013-2018) (Million US$)
Figure South Africa Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate (2013-2018) (K Units)
Figure South Africa Spinal Muscular Atrophy (SMA) Treatment Revenue Growth Rate (2013-2018) (Million US$)
Table Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Sales by Product (2013-2018) (K Units)
Table Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Sales Market Share by Product (2013-2018)
Figure 2017 Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Market Share by Product
Table Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Sales by End User (2013-2018) (K Units)
Table Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Sales Market Share by End User (2013-2018)
Figure 2017 Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Market Share by End User
Table Pfizer Company Details
Table Pfizer Spinal Muscular Atrophy (SMA) Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Pfizer Recent Development
Table Isis Pharmaceuticals Company Details
Table Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Isis Pharmaceuticals Recent Development
Table Biogen Idec Company Details
Table Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Biogen Idec Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Boehringer Ingelheim Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table F. Hoffmann-La Roche Recent Development
Table Regeneron Pharmaceuticals Company Details
Table Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Regeneron Pharmaceuticals Recent Development
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales Forecast by Regions 2018-2025 (K Units)
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales Market Share Forecast by Regions 2018-2025
Table Global Spinal Muscular Atrophy (SMA) Treatment Revenue Forecast by Regions 2018-2025 (Million US$)
Table Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share Forecast by Regions 2018-2025
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales Forecast by Product 2018-2025 (K Units)
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales Market Share Forecast by Product 2018-2025
Table Global Spinal Muscular Atrophy (SMA) Treatment Revenue Forecast by Product 2018-2025 (Million US$)
Table Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share Forecast by Product 2018-2025
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales Forecast by End User 2018-2025 (K Units)
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales Market Share Forecast by End User 2018-2025
Figure North America Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate Forecast (2018-2025) (K Units)
Figure North America Spinal Muscular Atrophy (SMA) Treatment Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Europe Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Europe Spinal Muscular Atrophy (SMA) Treatment Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Central & South America Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Central & South America Spinal Muscular Atrophy (SMA) Treatment Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Forecast of Global Middle-Class Population, 2015 to 2030
Figure Household Disposable Income Gross adjusted, US dollars/capita, 2016
Table Spinal Muscular Atrophy (SMA) Treatment Value Chain
Table Spinal Muscular Atrophy (SMA) Treatment Customers List
Table Spinal Muscular Atrophy (SMA) Treatment Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
